logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Ralf M Luche

This inventor holds 12 USPTO granted patents. Top assignee: Ceptyr, Inc.. Active years: 2002-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ralf M Luche. Retrieved from https://idiyas.com/inventor/ralf-m-luche

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal12 out of 15 
 
Ceptyr, Inc.
 patents

Years Active: 2002-2007

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7279299 - DSP-10 dual-specificity phosphatase (2007-10-09),
2. 7078210 - DSP-3 dual-specificity phosphatase (2006-07-18),
3. 7037702 - DSP-10 dual-specificity phosphatase (2006-05-02),
4. 7029898 - DSP-11 dual-specificity phosphatase (2006-04-18),
5. 6902919 - DSP-12 and DSP-13 dual-specificity phosphatases (2005-06-07),
6. 6852520 - DSP-2 dual-specificity phosphatase (2005-02-08),
7. 6841369 - DSP-4 dual specificity phosphatase (2005-01-11),
8. 6825021 - DSP-15 dual-specificity phosphatase (2004-11-30),
9. 6649391 - DSP-11 dual-specificity phosphatase (2003-11-18),
10. 6645753 - DSP-5 dual-specificity phosphatase (2003-11-11),
11. 6551810 - DSP-10 dual-specificity phosphatase (2003-04-22),
12. 6492157 - DSP-9 dual-specificity phosphatase (2002-12-10),

Title: Ralf M Luche: Innovator in Dual-Specificity Phosphatases

Introduction

Ralf M Luche is a prominent inventor based in Seattle, WA (US), known for his significant contributions to the field of biochemistry. He holds a total of 12 patents, showcasing his innovative approach to addressing complex biological processes. His work primarily focuses on dual-specificity phosphatases, which play a crucial role in cell proliferation, differentiation, and survival.

Latest Patents

Among his latest patents are the DSP-10 dual-specificity phosphatase and the DSP-3 dual-specificity phosphatase. The DSP-10 patent provides compositions and methods for treating conditions associated with cell proliferation, differentiation, and survival. This invention includes polypeptide variants that stimulate the dephosphorylation of DSP-10 substrates. These polypeptides can be utilized to identify antibodies and other agents that inhibit DSP-10 activity, thereby modulating cell functions. Similarly, the DSP-3 patent offers compositions and methods for the same biological conditions, focusing on the dual-specificity phosphatase DSP-3 and its polypeptide variants.

Career Highlights

Ralf M Luche is currently associated with Ceptyr, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding of dual-specificity phosphatases and their applications in medical treatments.

Collaborations

Ralf collaborates with Bo Wei, contributing to the innovative research environment at Ceptyr, Inc. Their combined expertise fosters advancements in the field of biochemistry.

Conclusion

Ralf M Luche's contributions to the field of dual-specificity phosphatases highlight his role as a leading inventor in biochemistry. His patents reflect a commitment to advancing medical science and improving treatment options for various conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…